Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK moves to boost patient influence on health service policy:

This article was originally published in Clinica

Executive Summary

Patient influence on the UK's increasingly decentralised health service policy is set to get a boost from the creation of the Patient and Public Involvement Resource Centre. From June 1, this national initiative will seek to "promote the value of involving people [in local services] and will work with NHS organisations, staff and patients". The move further underlines the opportunities and indeed importance for the medical technology industry in increasingly targeting their product information campaigns at the public. The Department of Health announced the project yesterday at the Patient Involvement, Empowerment and Information conference in London, after signing the contract for the service. The centre will be operated by a consortium comprising the University of Warwick, the Centre for Public Scrutiny and the Long-term Medical Conditions Alliance.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT051827

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel